Clinical trial Recruiting at 1 site Interventional Ages 18 to 100 Men only

Jeeejaculatory-Sparing HoLEP for Uprating Ejaculation During Prostate Surgery

Official title: Ejaculatory-sparing Holmium Laser Enucleation of the Prostate (HoLEP) vs Standard HoLEP: a Randomized Controlled Trial

Run by Northwestern University · NCT07631286 · Data updated 2026-11-12

A new ejaculatory-sparing HoLEP procedure is being tested to see if it can preserve ejaculation while treating enlarged prostate with urinary symptoms.

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexMen only
Enrollment48 (estimated)
SponsorNorthwestern University
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedJune 15, 2026
Main results expectedMay 2027
Study endsMay 2028
Registry record updatedAugust 20, 2026
Trial IDNCT07631286 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Men with enlarged prostate and bothersome urinary symptoms who are sexually active and currently have antegrade ejaculation, and who are candidates for HoLEP.

Probably not a fit

Patients who are not sexually active, have pre-existing retrograde ejaculation, or have conditions or circumstances that affect ejaculation or reading English may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares a novel ejaculatory-sparing HoLEP technique to standard HoLEP in men undergoing surgery for benign prostatic hyperplasia with bothersome urinary symptoms. The trial focuses on preserving antegrade ejaculation while achieving effective urinary outcomes. Participants are sexually active men without pre-existing retrograde ejaculation who require HoLEP and can read/speak English. The primary goal is to determine the efficacy of ES-HoLEP in maintaining ejaculation, with secondary assessment of urinary function post-surgery. Northwestern University leads the study at its Chicago site, with no listed collaborators.

Why it matters

Potential benefit: If successful, ES-HoLEP could help men preserve ejaculation after prostate surgery while still relieving urinary symptoms.

How similar studies have gone: Limited prior data on ejaculatory-sparing prostate procedures exist; this study explores a relatively novel approach in a well-defined surgical population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Patients who are sexually active with antegrade ejaculation who are undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms.

Exclusion Criteria:

* Patients with pre-existing retrograde ejaculation
* Patients who are not sexually active
* Patients with indwelling urinary catheter prior to surgery, neurological disease, or history of prior prostatic/urethral surgery that may impact ejaculation
* Patients who lack decisional capacity
* Patients unable to read/speak English

Where it's running

  • Northwestern University
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.